Cargando…
Iron-Dependent Cell Death: A New Treatment Approach against Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a devastating tumor type where a very high proportion of people diagnosed end up dying from cancer. Surgical resection is an option for only about 20% of patients, where the 5-year survival increase ranges from 10 to 25%. In addition to surgical resection,...
Autores principales: | Lopez-Blazquez, Carlos, Lacalle-Gonzalez, Carlos, Sanz-Criado, Lara, Ochieng’ Otieno, Michael, Garcia-Foncillas, Jesus, Martinez-Useros, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573128/ https://www.ncbi.nlm.nih.gov/pubmed/37834426 http://dx.doi.org/10.3390/ijms241914979 |
Ejemplares similares
-
DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer
por: Lacalle-Gonzalez, Carlos, et al.
Publicado: (2023) -
New Hope for Pancreatic Ductal Adenocarcinoma Treatment Targeting Endoplasmic Reticulum Stress Response: A Systematic Review
por: Garcia-Carbonero, Nuria, et al.
Publicado: (2018) -
Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
por: Martinez-Useros, Javier, et al.
Publicado: (2016) -
The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer
por: Martinez-Useros, Javier, et al.
Publicado: (2016) -
The Match between Molecular Subtypes, Histology and Microenvironment of Pancreatic Cancer and Its Relevance for Chemoresistance
por: Martinez-Useros, Javier, et al.
Publicado: (2021)